427 related articles for article (PubMed ID: 12707417)
21. Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Boukhris S; Magy L; Khalil M; Sindou P; Vallat JM
J Neurol Sci; 2007 Mar; 254(1-2):33-8. PubMed ID: 17286985
[TBL] [Abstract][Full Text] [Related]
22. Chronic neuropathies - chronic inflammatory demyelinating neuropathy and its variants.
Ramchandren S; Lewis RA
Front Neurol Neurosci; 2009; 26():12-25. PubMed ID: 19349703
[TBL] [Abstract][Full Text] [Related]
23. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome.
Saperstein DS; Amato AA; Wolfe GI; Katz JS; Nations SP; Jackson CE; Bryan WW; Burns DK; Barohn RJ
Muscle Nerve; 1999 May; 22(5):560-6. PubMed ID: 10331353
[TBL] [Abstract][Full Text] [Related]
24. Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy.
Yiannikas C; Vucic S
Muscle Nerve; 2008 Nov; 38(5):1447-1454. PubMed ID: 18932207
[TBL] [Abstract][Full Text] [Related]
25. Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy.
Shimizu F; Oishi M; Sawai S; Beppu M; Misawa S; Matsui N; Miyashiro A; Maeda T; Takeshita Y; Nishihara H; Sano Y; Sato R; Kaji R; Kuwabara S; Kanda T
J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):444-450. PubMed ID: 30523038
[TBL] [Abstract][Full Text] [Related]
26. Are electrophysiological criteria useful in distinguishing childhood demyelinating neuropathies?
Potulska-Chromik A; Ryniewicz B; Aragon-Gawinska K; Kabzinska D; Seroka A; Lipowska M; Kaminska AM; Kostera-Pruszczyk A
J Peripher Nerv Syst; 2016 Mar; 21(1):22-6. PubMed ID: 26663344
[TBL] [Abstract][Full Text] [Related]
27. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics.
Stewart JD; McKelvey R; Durcan L; Carpenter S; Karpati G
J Neurol Sci; 1996 Oct; 142(1-2):59-64. PubMed ID: 8902721
[TBL] [Abstract][Full Text] [Related]
28. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Narasimhan M
Clin Neurophysiol; 2007 Sep; 118(9):1999-2004. PubMed ID: 17644033
[TBL] [Abstract][Full Text] [Related]
29. [Incidence of diabetic neuropathy which fulfills electrophysiologic criteria of CIDP].
Miyasaki H; Hasegawa O; Mori I; Matsumoto S; Arita T
No To Shinkei; 1999 May; 51(5):415-8. PubMed ID: 10396747
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and long-term characteristics of the subtypes of chronic inflammatory demyelinating polyneuropathy].
Shimizu F; Nemoto J; Takeshita Y; Maeda T; Koga M; Kanda T
Rinsho Shinkeigaku; 2022 Mar; 62(3):173-177. PubMed ID: 35228460
[TBL] [Abstract][Full Text] [Related]
31. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.
Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV
Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614
[TBL] [Abstract][Full Text] [Related]
32. Patients who meet electrodiagnostic criteria for CIDP rarely present with a sensory predominant DSP phenotype.
Davalos L; London ZN; Stino AM; Gallagher GW; Callaghan BC; Wieland CM; Nowacek DG
Muscle Nerve; 2021 Jun; 63(6):881-884. PubMed ID: 33745140
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy.
Molenaar DS; Vermeulen M; de Haan R
J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):84-9. PubMed ID: 9436733
[TBL] [Abstract][Full Text] [Related]
34. Cranial nerve involvement in typical and atypical chronic inflammatory demyelinating polyneuropathies.
Shibuya K; Tsuneyama A; Misawa S; Suichi T; Suzuki Y; Kojima Y; Nakamura K; Kano H; Prado M; Kuwabara S
Eur J Neurol; 2020 Dec; 27(12):2658-2661. PubMed ID: 32876980
[TBL] [Abstract][Full Text] [Related]
35. [Chronic inflammatory demyelinating polyradiculoneuropathy: clinical heterogeneity and therapeutic perspectives].
Leger JM; Bombelli F; Tran-Thanh H; Chassande B; Maisonobe T; Viala K
Bull Acad Natl Med; 2010; 194(4-5):753-64; discussion 764-5. PubMed ID: 21568049
[TBL] [Abstract][Full Text] [Related]
36. Acquired inflammatory demyelinating neuropathies.
Ensrud ER; Krivickas LS
Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity and specificity of electrodiagnostic criteria for CIDP using ROC curves: comparison to patients with diabetic and MGUS associated neuropathies.
Wilson J; Chawla J; Fisher M
J Neurol Sci; 2005 Apr; 231(1-2):19-28. PubMed ID: 15792816
[TBL] [Abstract][Full Text] [Related]
38. [Immune-mediated neuropathies: indications and value of nerve biopsy].
Verschueren A
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S58-60. PubMed ID: 18087231
[TBL] [Abstract][Full Text] [Related]
39. Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for differentiation of demyelinating inflammatory and hereditary neuropathies.
Grimm A; Vittore D; Schubert V; Lipski C; Heiling B; Décard BF; Axer H
Clin Neurophysiol; 2016 Jul; 127(7):2618-24. PubMed ID: 27291881
[TBL] [Abstract][Full Text] [Related]
40. Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes.
Shimizu F; Sawai S; Sano Y; Beppu M; Misawa S; Nishihara H; Koga M; Kuwabara S; Kanda T
PLoS One; 2014; 9(8):e104205. PubMed ID: 25105500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]